{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:24Z","timestamp":1791216564902,"version":"4.1.0"},"reference-count":36,"publisher":"Japan Neurosurgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.2176\/nmccrj.cr.2020-0337","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T22:10:37Z","timestamp":1628201437000},"page":"451-456","source":"Crossref","is-referenced-by-count":3,"title":["Cerebral Hyperperfusion and Concomitant Reversible Lesion at the Splenium after Direct Revascularization Surgery for Adult Moyamoya Disease: Possible Involvement of MERS and Watershed Shift Phenomenon"],"prefix":"10.2176","volume":"8","author":[{"given":"Ryosuke","family":"TASHIRO","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Kohnan Hospital, Sendai, Miyagi, Japan"},{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"FUJIMURA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kohnan Hospital, Sendai, Miyagi, Japan"},{"name":"Division of Advanced Cerebrovascular Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"NISHIZAWA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"SAITO","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kohnan Hospital, Sendai, Miyagi, Japan"},{"name":"Division of Advanced Cerebrovascular Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"TOMINAGA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Fujimura M, Tominaga T: Current status of revascularization surgery for Moyamoya disease: special consideration for its \u2018internal carotid-external carotid (IC-EC) conversion\u2019 as the physiological reorganization system. <i>Tohoku J Exp Med<\/i> 236: 45\u201353,  2015","DOI":"10.1620\/tjem.236.45"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Jeon JP, Kim JE, Cho WS, Bang JS, Son YJ, Oh CW: Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. <i>J Neurosurg<\/i> 128: 793\u2013799, 2018","DOI":"10.3171\/2016.11.JNS161688"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T: Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. <i>Surg Neurol<\/i> 71: 442\u2013447, 2009","DOI":"10.1016\/j.surneu.2008.02.031"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T: Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. <i>Neurosurgery<\/i> 68: 957\u2013964; discussion 964\u2013965, 2011","DOI":"10.1227\/NEU.0b013e318208f1da"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T: Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. <i>Neurosurgery<\/i> 68: 957\u2013964; discussion 964\u2013965, 2011","DOI":"10.1227\/NEU.0b013e318208f1da"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Park W, Park ES, Lee S, et al.: Intracranial hemorrhage after superficial temporal artery-middle cerebral artery direct anastomosis for adults with moyamoya disease. <i>World Neurosurg<\/i> 119: e774\u2013e782,  2018","DOI":"10.1016\/j.wneu.2018.07.266"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tokairin K, Kazumata K, Uchino H, et al.: Postoperative intracerebral hemorrhage after combined revascularization surgery in moyamoya disease: profiles and clinical associations. <i>World Neurosurg<\/i> 120: e593\u2013e600, 2018","DOI":"10.1016\/j.wneu.2018.08.132"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ishikawa T, Yamaguchi K, Kawashima A, et al.: Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with moyamoya disease. <i>World Neurosurg<\/i> 119: e750\u2013e756, 2018","DOI":"10.1016\/j.wneu.2018.07.258"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tashiro R, Fujimura M, Katsuki M, et al.: Prolonged\/delayed cerebral hyperperfusion in adult patients with moyamoya disease with RNF213 gene polymorphism c.14576G&gt;A (rs112735431) after superficial temporal artery-middle cerebral artery anastomosis. <i>J Neurosurg<\/i> 23: 1\u20138, 2020","DOI":"10.3171\/2020.6.JNS201037"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kameyama M, Fujimura M, Tashiro R, et al.: Significance of quantitative cerebral blood flow measurement in the acute stage after revascularization surgery for adult moyamoya disease: implication for the pathological threshold of local cerebral hyperperfusion. <i>Cerebrovasc Dis<\/i> 48: 217\u2013225, 2019","DOI":"10.1159\/000504835"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Heros RC, Scott RM, Kistler JP, Ackerman RH, Conner ES: Temporary neurological deterioration after extracranial-intracranial bypass. <i>Neurosurgery<\/i> 15: 178\u2013185, 1984","DOI":"10.1227\/00006123-198408000-00006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hayashi T, Shirane R, Fujimura M, Tominaga T: Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. <i>J Neurosurg Pediatr<\/i> 6: 73\u201381, 2010","DOI":"10.3171\/2010.4.PEDS09478"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tu XK, Fujimura M, Rashad S, et al.: Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the &apos;watershed shift&apos;. <i>Neurosurg Rev<\/i> 40: 507\u2013512, 2017","DOI":"10.1007\/s10143-017-0845-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tashiro R, Fujimura M, Kameyama M, et al.: Incidence and risk factors of the watershed shift phenomenon after superficial temporal artery-middle cerebral artery anastomosis for adult moyamoya disease. <i>Cerebrovasc Dis<\/i> 47: 178\u2013187, 2019","DOI":"10.1159\/000500802"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yu J, Hu M, Ti L, Zhou K, Zhang J, Chen J: Paradoxical association of symptomatic cerebral edema with local hypoperfusion caused by \u2018watershed shift\u2019 after revascularization surgery for adult moyamoya disease: a case report. <i>Ther Adv Neurol Disord<\/i> 12: 1756287286419878343, 2019","DOI":"10.1177\/1756286419878343"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T: Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease. <i>Surg Neurol<\/i> 72: 476\u2013480; discussion 480, 2009","DOI":"10.1016\/j.surneu.2008.10.009"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kang HS, Kim JH, Phi JH, et al.: Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. <i>J Neurol Neurosurg Psychiatry<\/i> 81: 673\u2013678, 2010","DOI":"10.1136\/jnnp.2009.191817"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Fujimura M, Fujimura T, Kakizaki A, et al.: Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: involvement of intrinsic immune reaction in its pathogenesis. <i>Brain Res<\/i> 1679: 39\u201344, 2018","DOI":"10.1016\/j.brainres.2017.11.013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Hong SH, Wang KC, Kim SK, Cho BK, Park MH: Association of HLA-DR and -DQ genes with familial moyamoya disease in Koreans. <i>J Korean Neurosurg Soc<\/i> 46: 558\u2013563, 2009","DOI":"10.3340\/jkns.2009.46.6.558"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Tashiro R, Niizuma K, Khor SS, et al.: Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: a case-control study. <i>PLoS ONE<\/i> 14: e0220858, 2018.","DOI":"10.1371\/journal.pone.0220858"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T: Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. <i>Cerebrovasc Dis<\/i> 33: 436\u2013445, 2012","DOI":"10.1159\/000336765"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Fujimura M, Niizuma K, Inoue T, et al.: Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. <i>Neurosurgery<\/i> 74: 163\u2013170; discussion 170, 2014","DOI":"10.1227\/NEU.0000000000000238"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Fujimura M, Tominaga T: Significance of cerebral blood flow analysis in the acute stage after revascularization surgery for moyamoya disease. <i>Neurol Med Chir (Tokyo)<\/i> 55: 775\u2013781, 2015","DOI":"10.2176\/nmc.ra.2015-0063"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Fujimura M, Niizuma K, Endo H, et al.: Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease. <i>Neurol Res<\/i> 37: 131\u2013138, 2015","DOI":"10.1179\/1743132814Y.0000000432"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nishizawa T, Fujimura M, Katsuki M, et al.: Prediction of cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis by three-dimensional-time-of-flight magnetic resonance angiography in adult patients with moyamoya disease. <i>Cerebrovasc Dis<\/i> 49: 396\u2013403, 2020","DOI":"10.1159\/000509740"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Osuka S, Imai H, Ishikawa E, et al.: Mild encephalitis\/encephalopathy with a reversible splenial lesion: evaluation by diffusion tensor imaging. Two case reports. <i>Neurol Med Chir (Tokyo)<\/i> 50: 1118\u20131122, 2010","DOI":"10.2176\/nmc.50.1118"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Citton V, Burlina A, Baracchini C, et al.: Apparent diffusion coefficient restriction in the white matter: going beyond acute brain territorial ischemia. <i>Insights  Imaging<\/i> 3: 155\u2013164, 2012","DOI":"10.1007\/s13244-011-0114-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Miyata R, Tanuma N, Hayashi M, et al.: Oxidative stress in patients with clinically mild encephalitis\/encephalopathy with a reversible splenial lesion (MERS). <i>Brain Dev<\/i> 34: 124\u2013127, 2012","DOI":"10.1016\/j.braindev.2011.04.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Tashiro R, Fujimura M, Endo H, Endo T, Niizuma K, Tominaga T: Biphasic development of focal cerebral hyperperfusion after revascularization surgery for adult moyamoya disease associated with autosomal dominant polycystic kidney disease. <i>J Stroke Cerebrovasc Dis<\/i> 27: 3256\u20133260, 2018","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.024"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kawamura K, Fujimura M, Tashiro R, Kanoke A, Saito A, Tominaga T: Persistent local vasogenic edema with dynamic change in the regional cerebral blood flow after STA-MCA bypass for adult moyamoya disease. <i>J Stroke Cerebrovasc Dis<\/i> 29: 104625, 2020","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104625"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Ture U, Yasargil MG, Kright AF: The arteries of the corpus callosum: a microsurgical anatomic study. <i>Neurosurgery<\/i> 39: 1075\u20131084, 1996; discussion: 1084, 1075","DOI":"10.1097\/00006123-199612000-00001"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kahilogullari G, Comert A, Ozdemir M, et al.: Arterial vascularization patterns of the splenium: an anatomical study. <i>Clin Anat<\/i> 26: 675\u2013681, 2013","DOI":"10.1002\/ca.22114"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Fieshler J, Knudsen K, Kucinski T, et al.: Predictors of apparent diffusion coefficient normalization in stroke patients. <i>Stroke<\/i> 35: 514\u2013519, 2005","DOI":"10.1161\/01.STR.0000114873.28023.C2"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Shinoda N, Hori S, Mikami K, et al.: Utility of relative ADC ratio in patient selection for endovascular revascularization of large vessel occlusion. <i>J Neuroradiol<\/i> 44: 185\u2013191, 2017","DOI":"10.1016\/j.neurad.2016.12.015"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Fiehler J, Foth M, Kucinski T, et al.: Severe ADC decreases do not predict irreversible tissue damage in humans. <i>Stroke<\/i> 33: 79\u201386, 2002","DOI":"10.1161\/hs0102.100884"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Loh PS, Butcher KS, Parsons MW, et al.: Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. <i>Stroke<\/i> 36: 2626\u20132631, 2005","DOI":"10.1161\/01.STR.0000189688.95557.2b"}],"container-title":["NMC Case Report Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/8\/1\/8_cr.2020-0337\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:06:27Z","timestamp":1715144787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmccrj\/8\/1\/8_cr.2020-0337\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2176\/nmccrj.cr.2020-0337","relation":{},"ISSN":["2188-4226"],"issn-type":[{"value":"2188-4226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"cr.2020-0337"}}